BCAT2 and cancer: Translating BCAT2 inhibition to cancer means using it to push cancer cells into a metabolic corner—forcing them to either accumulate BCKAs or activate BCKDH and potentially overproduce ROS or deplete NAD+ (since BCKDH consumes NAD+).